Health Care Select Sector SPDR® ETF (XLV)
83.14
+0.98 +1.19%
NYSE Arca
Apr 26, 13:36
Delayed 2m
USD
XLV Key Stats
| Net Asset Value | Upgrade |
| Discount or Premium to NAV | Upgrade |
| Turnover Ratio | Upgrade |
View All XLV News
XLV News
-
WireHeadlineTime (ET)
-
MT Newswires04/26 13:10
-
MT Newswires04/26 09:23
-
MT Newswires04/25 13:26
-
MT Newswires04/25 09:21
-
MT Newswires04/24 13:14
-
MT Newswires04/24 09:25
-
MT Newswires04/23 13:26
-
MT Newswires04/23 09:24
-
MT Newswires04/20 15:01
-
MT Newswires04/20 13:33
XLV Performance
| Total Return (Price) | Total Return (NAV) | Cat. Total Return (NAV) | % Rank in Cat. (NAV) | |
|---|---|---|---|---|
| 1M | 3.13% | 3.10% | 0.61% | 20 |
| 3M | -7.99% | -8.00% | -6.66% | 53 |
| 6M | -0.26% | -0.29% | 2.39% | 76 |
| YTD | -0.28% | -0.19% | 1.22% | 67 |
| 1Y | 11.61% | 11.57% | 13.88% | 54 |
| 3Y | 4.96% | 4.96% | 2.01% | 23 |
| 5Y | 13.26% | 13.26% | 13.79% | 49 |
| 10Y | 11.91% | 11.91% | 12.96% | 66 |
XLV Asset Allocation
| Type | % Net | % Long | % Short |
|---|---|---|---|
| Cash | 0.17% | 0.17% | 0.00% |
| Stock | 99.83% | 99.83% | 0.00% |
| Bond | 0.00% | 0.00% | 0.00% |
| Convertible | 0.00% | 0.00% | 0.00% |
| Preferred | 0.00% | 0.00% | 0.00% |
| Other | 0.00% | 0.00% | 0.00% |
XLV Region Exposure
| Americas | 100.0% |
| North America | 100.0% |
| Latin America | 0.00% |
| Greater Europe | 0.00% |
| United Kingdom | 0.00% |
| Europe Developed | 0.00% |
| Europe Emerging | 0.00% |
| Africa/Middle East | 0.00% |
| Greater Asia | 0.00% |
| Japan | 0.00% |
| Australasia | 0.00% |
| Asia Developed | 0.00% |
| Asia Emerging | 0.00% |
| Market Classification | |
| % Developed Markets | 100.0% |
| % Emerging Markets | 0.00% |
XLV Stock Sector Exposure
| Basic Materials | 0.00% |
| Communication Services | 0.00% |
| Consumer Cyclical | 0.00% |
| Consumer Defensive | 0.00% |
| Energy | 0.00% |
| Financial Services | 0.00% |
| Healthcare | 99.41% |
| Industrials | 0.00% |
| Real Estate | 0.00% |
| Technology | 0.59% |
| Utilities | 0.00% |
XLV Stock Market Capitalization
| Giant | 56.74% |
| Large | 38.27% |
| Medium | 4.99% |
| Small | 0.00% |
| Micro | 0.00% |
XLV Stock Style Exposure
| Large Cap Value | 38.04% |
| Large Cap Blend | 25.86% |
| Large Cap Growth | 31.11% |
| Mid Cap Value | 0.82% |
| Mid Cap Blend | 2.57% |
| Mid Cap Growth | 1.60% |
| Small Cap Value | 0.00% |
| Small Cap Blend | 0.00% |
| Small Cap Growth | 0.00% |
View More Holdings
As of April 24, 2018
XLV Top 10 Holdings
| Symbol | Name | % Weight | Price | % Chg |
|---|---|---|---|---|
| JNJ | Johnson & Johnson | 10.90% | 128.90 | +1.69% |
| UNH | UnitedHealth Group Inc | 7.30% | 237.26 | +1.00% |
| PFE | Pfizer Inc | 7.10% | 37.05 | +1.01% |
| MRK | Merck & Co Inc | 5.22% | 59.57 | -0.10% |
| ABBV | AbbVie Inc | 4.69% | 96.33 | +4.85% |
| AMGN | Amgen Inc | 3.70% | 174.95 | +0.07% |
| MDT | Medtronic PLC | 3.46% | 80.28 | +1.03% |
| ABT | Abbott Laboratories | 3.26% | 59.22 | +0.97% |
| GILD | Gilead Sciences Inc | 3.07% | 73.04 | -0.29% |
| TMO | Thermo Fisher Scientific Inc | 2.76% | 214.58 | +0.05% |
Advertisement
XLV One Page Reports
- One Page Report Download
XLV Basic Info
| Style | |
|---|---|
| Equity Style | Large Cap/Blend |
| Broad Asset Class | Sector Equity |
| Broad Category | Equity |
| Category Name | Health |
| Prospectus Objective | Specialty - Health |
| Fund Owner Firm Name | SPDR State Street Global Advisors |
| Benchmark Index | |
|---|---|
S&P Health Care Select Sector TR USD |
100.0% |
XLV Manager Info
| Name | Tenure |
|---|---|
| Dwayne Hancock | 1.08 yrs |
| Karl Schneider | 3.01 yrs |
| Michael Feehily | 7.01 yrs |
XLV Net Fund Flows
| 1M | 85.59M |
| 3M | -1.053B |
| 6M | -2.419B |
| YTD | -1.053B |
| 1Y | -2.108B |
| 3Y | -498.56M |
| 5Y | 2.283B |
| 10Y | 5.356B |
XLV Risk Info
| Beta (5Y) | 0.9066 |
| Max Drawdown (All) | 39.17% |
| Historical Sharpe (10Y) | 0.8931 |
| Historical Sortino (All) | 0.70 |
| 30-Day Rolling Volatility | 19.78% |
| Daily Value at Risk (VaR) 1% (All) | 3.04% |
| Monthly Value at Risk (VaR) 1% (All) | 13.21% |
XLV Fundamentals
| Dividend Yield TTM (4-26-18) | 1.49% |
| SEC Yield (4-24-18) | 1.53% |
| Weighted Average PE Ratio | 25.93 |
| Weighted Average Price to Sales Ratio | 1.807 |
| Weighted Average Price to Book Ratio | 3.844 |
| Weighted Median ROE | 17.33% |
| Weighted Median ROA | 5.30% |
| Forecasted Dividend Yield | 1.79% |
| Forecasted PE Ratio | 15.30 |
| Forecasted Price to Sales Ratio | 1.690 |
| Forecasted Price to Book Ratio | 3.451 |
| Number of Holdings | 62 |
XLV Growth Estimates
| Forecasted 5 Yr Earnings Growth | 10.74% |
| Forecasted Book Value Growth | 7.05% |
| Forecasted Cash Flow Growth | 7.39% |
| Forecasted Earnings Growth | -0.11% |
| Forecasted Revenue Growth | 8.15% |
XLV Attributes
| Key Dates | |
|---|---|
| Inception Date | 12/16/1998 |
| Termination Date | |
| Last Annual Report Date | 9/30/2017 |
| Last Prospectus Date | 1/31/2018 |
| Attributes | |
| Exchange Traded Share | Yes |
| Exchange Traded Note | No |
| Enhanced Index Fund | No |
| Index Fund | Yes |
| Inverse Fund | No |
| Leveraged Fund | No |
| Fund of Funds | No |
| Currency Hedged Fund | No |
| Synthetic Replication Fund | No |
| Has Dividend Investment Plan | Yes |
| General Availability | |
| Available for Insurance Product | No |
| Available for Retirement Plan | No |
| Available for RRSP | No |
XLV Excel Add-In Codes
- Name: =YCI("XLV","name")
- Broad Asset Class: =YCI("XLV", "broad_asset_class")
- Broad Category: =YCI("XLV", "broad_category_group")
- Prospectus Objective: =YCI("XLV", "prospectus_objective")
To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.
Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.
Advertisement
